Amboss
A breakthrough learning and knowledge system for medical students and physicians.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
* | €240m | Late VC | |
| Total Funding | 000k | ||
| EUR | 2013 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
Related Content
AMBOSS is a medical technology company with offices in New York, Berlin, Cologne and Cagliari. Its knowledge platform has fundamentally changed the way medical know-how is acquired and utilized at the point of care. Students use the interactive library and high-yield question bank for general study and exam preparation, while clinicians rely on AMBOSS to make effective clinical decisions guided by evidence-based recommendations.
Founded in 2012 by physicians for physicians, the company’s international team has grown to over 400 physicians, scientists and software engineers, all striving to better serve physicians around the world. Today, more than a million healthcare professionals in over 180 countries rely on AMBOSS.
Tech stack
Investments by Amboss
Edit